China to speed up drug approvals, will accept overseas trial data

SHANGHAI (Reuters) – China is looking to speed up approvals for new drugs and plans to accept data from clinical trials carried out overseas, a potential boon for international drugmakers and patients who often face lengthy delays for new medicines to reach the market.


Reuters: Health News

About the author

Comments are closed.